Total Payments
$107,325
2024 Payments
$40,816
Companies
9
Transactions
187
Medicare Patients
2,643
Medicare Billing
$293,053
Payment Breakdown by Category
Consulting$53,287 (49.7%)
Other$35,583 (33.2%)
Travel$13,024 (12.1%)
Food & Beverage$4,105 (3.8%)
Research$1,306 (1.2%)
Education$20.59 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $53,287 | 21 | 49.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,583 | 16 | 33.2% |
| Travel and Lodging | $13,024 | 63 | 12.1% |
| Food and Beverage | $4,105 | 80 | 3.8% |
| Unspecified | $1,306 | 5 | 1.2% |
| Education | $20.59 | 2 | 0.0% |
Payments by Type
General
$106,019
182 transactions
Research
$1,306
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| United Therapeutics Corporation | $75,898 | 119 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $14,693 | 23 | $0 (2023) |
| Merck Sharp & Dohme LLC | $7,439 | 11 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $4,747 | 14 | $0 (2024) |
| Gilead Sciences Inc | $3,710 | 13 | $0 (2017) |
| Breathe Technologies, Inc. | $500.00 | 1 | $0 (2019) |
| Insmed, Inc. | $150.00 | 1 | $0 (2022) |
| Advanced Respiratory, Inc | $108.53 | 4 | $0 (2021) |
| Sandoz Inc. | $79.66 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,816 | 61 | United Therapeutics Corporation ($28,896) |
| 2023 | $22,620 | 36 | United Therapeutics Corporation ($20,511) |
| 2022 | $9,114 | 18 | United Therapeutics Corporation ($7,002) |
| 2021 | $6,704 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($3,300) |
| 2020 | $4,985 | 4 | United Therapeutics Corporation ($4,860) |
| 2019 | $19,151 | 42 | United Therapeutics Corporation ($11,243) |
| 2018 | $147.92 | 2 | United Therapeutics Corporation ($91.49) |
| 2017 | $3,787 | 14 | Gilead Sciences Inc ($3,710) |
All Payment Transactions
187 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $30.77 | General |
| 12/09/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $21.31 | General |
| 12/09/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $17.00 | General |
| 11/19/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| 11/14/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Travel and Lodging | Cash or cash equivalent | $97.74 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Travel and Lodging | Cash or cash equivalent | $71.00 | General |
| Category: Cardiology | ||||||
| 10/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | Cash or cash equivalent | $37.83 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $13.43 | General |
| 10/18/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| 10/16/2024 | United Therapeutics Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| 10/11/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $155.00 | General |
| 10/10/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $168.97 | General |
| 10/10/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $40.31 | General |
| 10/10/2024 | United Therapeutics Corporation | — | Travel and Lodging | In-kind items and services | $15.94 | General |
| 10/08/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $108.47 | General |
| 10/05/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $89.56 | General |
| Category: Cardiology | ||||||
| 10/05/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Travel and Lodging | In-kind items and services | $516.22 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Travel and Lodging | In-kind items and services | $78.49 | General |
| Category: Cardiology | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $151.42 | General |
| 09/25/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $32.77 | General |
| 09/09/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $31.07 | General |
| 09/09/2024 | United Therapeutics Corporation | — | Travel and Lodging | Cash or cash equivalent | $30.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION PH IN HEART FAILURE WITH PRESERVED EJECTION FRACTION HFPEF | United Therapeutics Corporation | $1,156 | 4 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib Administered Once Daily for 52 Weeks in Subjects With Non-Cystic Fibrosis Bronchiectasis - The ASPEN Study | Insmed, Inc. | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 802 | 994 | $295,886 | $64,928 |
| 2022 | 11 | 594 | 769 | $284,806 | $61,612 |
| 2021 | 12 | 683 | 967 | $373,778 | $91,060 |
| 2020 | 11 | 564 | 801 | $323,403 | $75,453 |
Total Patients
2,643
Total Services
3,531
Medicare Billing
$293,053
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 47 | 106 | $101,760 | $16,997 | 16.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 74 | 132 | $51,348 | $16,209 | 31.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 59 | 91 | $35,399 | $9,096 | 25.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 60 | $21,000 | $5,403 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 38 | $9,842 | $3,532 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $10,290 | $3,252 | 31.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 17 | 17 | $8,330 | $2,318 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 23 | $5,957 | $1,693 | 28.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 13 | 18 | $8,496 | $1,460 | 17.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,506 | $943.88 | 37.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 86 | 86 | $4,648 | $665.53 | 14.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 38 | 38 | $3,654 | $637.31 | 17.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 100 | 100 | $11,788 | $632.92 | 5.4% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 99 | 104 | $11,856 | $622.16 | 5.2% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 38 | 38 | $3,572 | $620.49 | 17.4% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 69 | 69 | $3,174 | $441.54 | 13.9% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 24 | 24 | $1,200 | $216.96 | 18.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 15 | 15 | $1,066 | $187.66 | 17.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 52 | 148 | $142,080 | $23,585 | 16.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 101 | $37,434 | $12,664 | 33.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 44 | 65 | $24,025 | $7,028 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 44 | $10,844 | $4,074 | 37.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $7,390 | $2,684 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 32 | $11,200 | $2,487 | 22.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $6,455 | $1,820 | 28.2% |
About Dr. Rahul Argula, MBBS
Dr. Rahul Argula, MBBS is a Internal Medicine healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386841583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rahul Argula, MBBS has received a total of $107,325 in payments from pharmaceutical and medical device companies, with $40,816 received in 2024. These payments were reported across 187 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($53,287).
As a Medicare-enrolled provider, Argula has provided services to 2,643 Medicare beneficiaries, totaling 3,531 services with total Medicare billing of $293,053. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Charleston, SC
- Active Since 06/29/2007
- Last Updated 03/02/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1386841583
Products in Payments
- TYVASO (Drug) $17,368
- Adempas (Drug) $11,393
- ORENITRAM (Drug) $8,635
- NONE (Drug) $4,717
- UPTRAVI (Drug) $4,613
- Letairis (Drug) $3,710
- WINREVAIR (Biological) $1,713
- Life2000 Ventilation System (Device) $500.00
- Arikayce (Drug) $150.00
- OPSUMIT MACITENTAN (Drug) $133.76
- REMODULIN (Drug) $93.99
- Life 2000 Ventilation System (Device) $84.40
- TREPROSTINIL (Drug) $79.66
- The Vest System Model 105 Home Care (Device) $24.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Internal Medicine $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Internal Medicine $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Internal Medicine $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Internal Medicine $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518
Internal Medicine $202,518